Literature DB >> 24920806

A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes.

Jason P Laliberte1, Bernard Moss2.   

Abstract

UNLABELLED: Superinfection exclusion is a widespread phenomenon that prevents secondary infections by closely related viruses. The vaccinia virus A56 and K2 proteins in the cell membrane can prevent superinfection by interacting with the entry-fusion complex of subsequent viruses. Here, we described another form of exclusion that is established earlier in infection and does not require the A56 or K2 protein. Cells infected with one or more infectious virions excluded hundreds of superinfecting vaccinia virus particles. A related orthopoxvirus, but neither a flavivirus nor a rhabdovirus, was also excluded, indicating selectivity. Although superinfecting vaccinia virus bound to cells, infection was inhibited at the membrane fusion step, thereby preventing core entry into the cytoplasm and early gene expression. In contrast, A56/K2 protein-mediated exclusion occurred subsequent to membrane fusion. Induction of resistance to superinfection depended on viral RNA and protein synthesis by the primary virus but did not require DNA replication. Although superinfection resistance correlated with virus-induced changes in the cytoskeleton, studies with mutant vaccinia viruses indicated that the cytoskeletal changes were not necessary for resistance to superinfection. Interferon-inducible transmembrane proteins, which can inhibit membrane fusion in other viral systems, did not prevent vaccinia virus membrane fusion, suggesting that these interferon-inducible proteins are not involved in superinfection exclusion. While the mechanism remains to be determined, the early establishment of superinfection exclusion may provide a "winner-take-all" reward to the first poxvirus particles that successfully initiate infection and prevent the entry and genome reproduction of defective or less fit particles. IMPORTANCE: The replication of a virus usually follows a defined sequence of events: attachment, entry into the cytoplasm or nucleus, gene expression, genome replication, assembly of infectious particles, and spread to other cells. Although multiple virus particles may enter a cell at the same time, mechanisms exist to prevent infection by subsequent viruses. The latter phenomenon, known as superinfection exclusion, can occur by a variety of mechanisms that are not well understood. We showed that superinfection by vaccinia virus was prevented at the membrane fusion step, which closely followed virion attachment. Thus, neither gene expression nor genome replication of the superinfecting virus occurred. Expression of early proteins by the primary virus was necessary and sufficient to induce the superinfection-resistant state. Superinfection exclusion may be beneficial to vaccinia virus by selecting particles that can infect cells rapidly, excluding defective particles and synchronizing the replication cycle.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24920806      PMCID: PMC4136360          DOI: 10.1128/JVI.00816-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.

Authors:  Wolfgang Resch; Bernard Moss
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.

Authors:  Cheng-Yen Huang; Tsai-Yi Lu; Chi-Horng Bair; Yuan-Shau Chang; Jeng-Kuan Jwo; Wen Chang
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

3.  Vaccinia virus A21 virion membrane protein is required for cell entry and fusion.

Authors:  Alan C Townsley; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion.

Authors:  Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication.

Authors:  Young-Min Lee; Donna M Tscherne; Sang-Im Yun; Ilya Frolov; Charles M Rice
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling.

Authors:  Ferran Valderrama; João V Cordeiro; Sibylle Schleich; Friedrich Frischknecht; Michael Way
Journal:  Science       Date:  2006-01-20       Impact factor: 47.728

7.  Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.

Authors:  Timothy R Wagenaar; Suany Ojeda; Bernard Moss
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus.

Authors:  Peter C Turner; Richard W Moyer
Journal:  Virology       Date:  2008-08-28       Impact factor: 3.616

9.  Vaccinia virus l1 protein is required for cell entry and membrane fusion.

Authors:  Himani Bisht; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

10.  The vaccinia virus F11L gene product facilitates cell detachment and promotes migration.

Authors:  Ivonne Morales; Maria Alejandra Carbajal; Stefan Bohn; Daniela Holzer; Sayuri E M Kato; Frederico A B Greco; Nissin Moussatché; Jacomine Krijnse Locker
Journal:  Traffic       Date:  2008-06-28       Impact factor: 6.215

View more
  16 in total

1.  Identification of Parameters of Host Cell Vulnerability during Salmonella Infection by Quantitative Image Analysis and Modeling.

Authors:  Jakub Voznica; Christophe Gardella; Ilia Belotserkovsky; Alexandre Dufour; Jost Enninga; Virginie Stévenin
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

2.  The Matrix Protein of a Plant Rhabdovirus Mediates Superinfection Exclusion by Inhibiting Viral Transcription.

Authors:  Xin Zhou; Kai Sun; Xueping Zhou; Andrew O Jackson; Zhenghe Li
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 3.  Virological and Immunological Outcomes of Coinfections.

Authors:  Naveen Kumar; Shalini Sharma; Sanjay Barua; Bhupendra N Tripathi; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2018-07-05       Impact factor: 26.132

Review 4.  Exploitation of Cytoskeletal Networks during Early Viral Infection.

Authors:  Derek Walsh; Mojgan H Naghavi
Journal:  Trends Microbiol       Date:  2018-07-20       Impact factor: 17.079

5.  The Coat Protein and NIa Protease of Two Potyviridae Family Members Independently Confer Superinfection Exclusion.

Authors:  Satyanarayana Tatineni; Roy French
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

Review 6.  Membrane fusion during poxvirus entry.

Authors:  Bernard Moss
Journal:  Semin Cell Dev Biol       Date:  2016-07-14       Impact factor: 7.727

Review 7.  Extracellular Virions: The Advance Guard of Poxvirus Infections.

Authors:  David J Pickup
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

8.  Classical Swine Fever Virus vs. Classical Swine Fever Virus: The Superinfection Exclusion Phenomenon in Experimentally Infected Wild Boar.

Authors:  Sara Muñoz-González; Marta Pérez-Simó; Andreu Colom-Cadena; Oscar Cabezón; José Alejandro Bohórquez; Rosa Rosell; Lester Josué Pérez; Ignasi Marco; Santiago Lavín; Mariano Domingo; Llilianne Ganges
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

9.  gD-Independent Superinfection Exclusion of Alphaherpesviruses.

Authors:  A Criddle; T Thornburg; I Kochetkova; M DePartee; M P Taylor
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 10.  A comparative review of viral entry and attachment during large and giant dsDNA virus infections.

Authors:  Haitham Sobhy
Journal:  Arch Virol       Date:  2017-09-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.